ATRA - Atara Biotherapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development167,45781,20656,51441,618
Selling General and Administrative69,65440,32624,72816,830
Non Recurring----
Total Operating Expenses237,111121,53281,24258,448
Operating Income or Loss-237,111-121,532-81,242-58,448
Income from Continuing Operations
Total Other Income/Expenses Net6,3684,0542,2031,218
Earnings Before Interest and Taxes-237,111-121,532-81,242-58,448
Interest Expense----
Income Before Tax-230,743-119,505-79,039-57,230
Income Tax Expense-44-1410-9
Minority Interest----
Net Income From Continuing Ops-230,699-119,491-79,049-57,221
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-230,699-119,491-79,049-57,221
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-230,699-119,491-79,049-57,221